Albert, Nathalie L. http://orcid.org/0000-0003-0953-7624
Preusser, Matthias http://orcid.org/0000-0003-3541-2315
Traub-Weidinger, Tatjana http://orcid.org/0000-0003-1118-926X
Tolboom, Nelleke http://orcid.org/0000-0002-8005-2833
Law, Ian
Palmer, Joshua D. http://orcid.org/0000-0003-3311-0129
Guedj, Eric
Furtner, Julia http://orcid.org/0000-0001-8258-3681
Fraioli, Francesco
Huang, Raymond Y.
Johnson, Derek R.
Deroose, Christophe M. http://orcid.org/0000-0002-6080-1577
Herrmann, Ken http://orcid.org/0000-0002-9662-7259
Vogelbaum, Michael
Chang, Susan
Tonn, Joerg-Christian
Weller, Michael
Wen, Patrick Y.
van den Bent, Martin J.
Verger, Antoine
Ivanidze, Jana
Galldiks, Norbert
Funding for this research was provided by:
Klinikum der Universität München
Article History
Received: 4 April 2024
Accepted: 30 May 2024
First Online: 20 June 2024
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: NLA has received honoraria for lectures, consultation or advisory board participation from Novartis, Advanced Accelerator Applications, Servier, OncLive and Telix Pharmaceuticals and research funding from Novocure.MP has received honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Bayer, Bristol-Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, BMJ Journals, MedMedia, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, Sanofi, Merck Sharp & Dome, Tocagen, Adastra, Gan & Lee Pharmaceuticals, Servier, Miltenyi, Böhringer-Ingelheim, Telix, Medscape, OncLive.AV has received honoraria for lectures and advisory board participation from Curium, Eisai and General Electrics.CMD is/has been a consultant for: Sirtex, Advanced Accelerator Applications, Novartis, Ipsen, Terumo, PSI CRO. He has received travel fees from: GE Healthcare, Sirtex.KH reports personal fees from Bayer, personal fees and other from Sofie Biosciences, personal fees from SIRTEX, non-financial support from ABX, personal fees from Adacap, personal fees from Curium, personal fees from Endocyte, grants and personal fees from BTG, personal fees from IPSEN, personal fees from Siemens Healthineers, personal fees from GE Healthcare, personal fees from Amgen, personal fees from Fusion, personal fees from Immedica, personal fees from Onkowissen.de, personal fees from Novartis, personal fees from Molecular Partners, personal fees from ymabs, personal fees from Aktis Oncology, personal fees from Theragnostics, personal fees from Pharma15, personal fees from Debiopharm, personal fees from AstraZeneca, personal fees from Janssen.JCT has received research grants and honoraria for lectures, consultation or advisory board participation from the following for-profit companies: AAA-Novartis, Seagen, CarThera, Munich Surgical Imaging, Novocure.PYW has received research support from Astra Zeneca, Black Diamond, Bristol Meyers Squibb, Celgene, Chimerix, Eli Lily, Erasca, Genentech/Roche, Kazia, MediciNova, Merck, Novartis, Nuvation Bio, Servier, Vascular Biogenics, VBI Vaccines and honoraria for consultation or advisiory board participation from Astra Zeneca, Black Diamond, Celularity, Chimerix, Day One Bio, Genenta, Glaxo Smith Kline, Merck, Mundipharma, Novartis, Novocure, Nuvation Bio, Prelude Therapeutics, Sapience, Servier, Sagimet, Vascular Biogenics, VBI Vaccines.JF has received honoraria for lectures and consultations from the following for-profit companies: Novartis, Seagen, Sanova, Servier.JI has received research support from Novartis Pharmaceuticals (funds paid to institution, investigator-initiated trial grant).RYH has received honoraria for consultation from Nuvation Bio, Servier and Telix, and honoraria for participiation in Scientific Advisory Boards from Vysioneer.DRJ has received honoraria for consultation or advisory board participation from Novartis and Telix Pharmaceuticals.EG has received honoraria for consultation or advisory board participation from Novartis.JDP reports grants from the NIH and Genentech; Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Varian Medical Systems, Novocure, ICOTEC; Travel support from Varian, ICOTEC; Participation on a Data Safety Monitoring Board or Advisory Board from Novocure.MVDB has received honoraria for consultancy from Chimerix, Servier, Astra Zeneca, Boehringer-Ingelheim, Nerviano, Incyte, Biopharma, and Genenta.NG has received honoraria for lectures from Blue Earth Diagnostics, and for advisory board participation from Telix Pharmaceuticals.